Back

Transcriptomic, Genomic, and Clinical Characterization of Morphological Classes in Localized and Metastatic Pancreatic Cancer

Flores-Figueroa, E.; Fang, Y.; Elqaderi, A.; Monajemzadeh, M.; Zang, A.; Jang, G. H.; Chan-Seng-Yue, M.; Ng, K.; Ouellette, T.; Ramotar, S.; Bevacqua, D.; Hutchinson, S.; Ding, R. Y.; Liang, S.-B.; Hasnain, S. M.; O'Kane, G. M.; Fisher, S.; Nowak, K.; Grunwald, B.; Dodd, A.; Wilson, J. M.; Tsang, E.; Gallinger, S.; Knox, J. J.; Notta, F.; Grant, R. C.

2026-04-10 cancer biology
10.64898/2026.04.07.717011 bioRxiv
Show abstract

BackgroundHistomorphology is a strong prognostic biomarker correlated with basal-like and classical programs in surgically resected pancreatic ductal adenocarcinoma (PDAC). However, the spectrum of morphology and its biological associations remain poorly defined in advanced disease. ObjectivesWe explored the transcriptomic and genomic underpinnings and clinical relevance of morphological classes across localized and metastatic PDAC. DesignWe unified morphological classifications into four classes: glandular, cribriform, solid, and squamous. We integrated transcriptome and whole-genome sequencing following laser-capture microdissection with morphological classifications in 348 PDAC patients, where half of the cohort included locally advance and metastatic stages to uncover molecular associations. ResultsNon-glandular morphologies comprised three distinct classes that were enriched in metastatic disease. Transcriptomic profiling exhibited that glandular tumours predominantly expressed classical epithelial programs, although a subset displayed partial or full epithelial- mesenchymal transition signatures. In contrast, non-glandular morphologies showed basal-like transcriptional programs with subtype-specific pathways, including ciliogenesis in cribriform tumours, extracellular matrix remodelling and immune evasion in solid tumours, and keratinisation programs in squamous tumours. The solid class was significantly enriched in liver metastatic lesions and was associated with increased intra-tumoural morphological heterogeneity, whole-genome doubling, KRAS major allelic imbalance, and elevated KRAS-ERK signalling. ConclusionNon-glandular morphologies identify biologically distinct PDAC tumour states that are enriched in liver metastases and associated with subtype-specific transcriptional programs and KRAS-driven genomic alterations.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Gut
36 papers in training set
Top 0.1%
18.8%
2
Gastroenterology
40 papers in training set
Top 0.2%
10.1%
3
The Journal of Pathology
22 papers in training set
Top 0.1%
9.2%
4
PLOS ONE
4510 papers in training set
Top 36%
4.0%
5
British Journal of Cancer
42 papers in training set
Top 0.3%
4.0%
6
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.2%
3.7%
7
Scientific Reports
3102 papers in training set
Top 36%
3.6%
50% of probability mass above
8
International Journal of Cancer
42 papers in training set
Top 0.3%
3.6%
9
BMC Cancer
52 papers in training set
Top 0.7%
3.1%
10
Clinical Cancer Research
58 papers in training set
Top 0.8%
1.9%
11
Cancer Medicine
24 papers in training set
Top 0.6%
1.9%
12
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.6%
1.8%
13
Nature Communications
4913 papers in training set
Top 50%
1.8%
14
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.3%
1.7%
15
Frontiers in Oncology
95 papers in training set
Top 2%
1.7%
16
Laboratory Investigation
13 papers in training set
Top 0.1%
1.7%
17
npj Precision Oncology
48 papers in training set
Top 0.7%
1.5%
18
Cancers
200 papers in training set
Top 3%
1.3%
19
EBioMedicine
39 papers in training set
Top 0.5%
1.3%
20
PLOS Computational Biology
1633 papers in training set
Top 20%
1.2%
21
eBioMedicine
130 papers in training set
Top 3%
1.0%
22
JCI Insight
241 papers in training set
Top 6%
0.9%
23
Molecular Cancer Research
42 papers in training set
Top 0.6%
0.9%
24
Modern Pathology
21 papers in training set
Top 0.3%
0.9%
25
Molecular Oncology
50 papers in training set
Top 0.8%
0.9%
26
Genome Medicine
154 papers in training set
Top 7%
0.8%
27
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
28
Cancer Research
116 papers in training set
Top 3%
0.8%
29
Cancer Research Communications
46 papers in training set
Top 1%
0.7%
30
Science Advances
1098 papers in training set
Top 30%
0.7%